PULMONX CORPORATION Capital Expenditures Incurred but Not yet Paid
PULMONX CORPORATION (LUNG) reported Capital Expenditures Incurred but Not yet Paid of $8.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-04
- PULMONX CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $8.00K, a 87.88% decline year-over-year.
- PULMONX CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$4.00K.
- PULMONX CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$63.00K, a 184.00% decline year-over-year.
- PULMONX CORPORATION capital expenditures incurred but not yet paid for fiscal 2025 was $8.00K, a 96.33% decline from fiscal 2024.
- PULMONX CORPORATION capital expenditures incurred but not yet paid for fiscal 2024 was $218.00K, a 100.00% increase from fiscal 2023.
- PULMONX CORPORATION capital expenditures incurred but not yet paid for fiscal 2023 was $109.00K, a 74.35% decline from fiscal 2022.
- PULMONX CORPORATION capital expenditures incurred but not yet paid for fiscal 2022 was $425.00K, a 27.23% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $8.00K 10-Q · filed 2026-08-04 | $4.00K derived: sum of 3 quarters · filed 2026-08-04 | -$59.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-04 | -$4.00K derived: sum of 2 quarters · filed 2026-05-04 | -$67.00K derived: sum of 3 quarters · filed 2026-05-04 | -$1.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$67.00K derived: sum of 2 quarters · filed 2026-03-10 | -$1.00K derived: sum of 3 quarters · filed 2026-08-04 | $8.00K 10-K · filed 2026-03-10 |
| 2025-09-30 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.00K derived: sum of 2 quarters · filed 2026-08-04 | $12.00K 10-Q · filed 2025-11-12 | -$14.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $75.00K 10-Q · filed 2026-08-04 | $49.00K derived: sum of 3 quarters · filed 2026-08-04 | $124.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $9.00K 10-Q · filed 2026-05-04 | -$17.00K derived: sum of 2 quarters · filed 2026-05-04 | $58.00K derived: sum of 3 quarters · filed 2026-05-04 | $127.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $49.00K derived: sum of 2 quarters · filed 2026-03-10 | $118.00K derived: sum of 3 quarters · filed 2026-03-10 | $218.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $144.00K derived: sum of 2 quarters · filed 2025-11-12 | $244.00K 10-Q · filed 2025-11-12 | $296.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $169.00K 10-Q · filed 2025-08-01 | $221.00K derived: sum of 3 quarters · filed 2025-08-01 | -$172.00K derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $100.00K 10-Q · filed 2025-05-02 | $152.00K derived: sum of 2 quarters · filed 2025-05-02 | -$241.00K derived: sum of 3 quarters · filed 2025-05-02 | -$260.00K derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$341.00K derived: sum of 2 quarters · filed 2025-02-25 | -$360.00K derived: sum of 3 quarters · filed 2025-02-25 | $109.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | -$393.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | -$412.00K derived: sum of 2 quarters · filed 2024-11-01 | $57.00K 10-Q · filed 2024-11-01 | -$18.00K derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $450.00K 10-Q · filed 2024-08-02 | $375.00K derived: sum of 3 quarters · filed 2024-08-02 | $389.00K derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $469.00K 10-Q · filed 2024-05-03 | $394.00K derived: sum of 2 quarters · filed 2024-05-03 | $408.00K derived: sum of 3 quarters · filed 2024-05-03 | $438.00K derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | -$75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$61.00K derived: sum of 2 quarters · filed 2024-02-27 | -$31.00K derived: sum of 3 quarters · filed 2024-02-27 | $425.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $44.00K derived: sum of 2 quarters · filed 2023-11-03 | $500.00K 10-Q · filed 2023-11-03 | $19.00K derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $486.00K 10-Q · filed 2023-08-04 | $5.00K derived: sum of 3 quarters · filed 2023-08-04 | $462.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $456.00K 10-Q · filed 2023-05-08 | -$25.00K derived: sum of 2 quarters · filed 2023-05-08 | $432.00K derived: sum of 3 quarters · filed 2023-05-08 | $896.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$481.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$24.00K derived: sum of 2 quarters · filed 2023-03-01 | $440.00K derived: sum of 3 quarters · filed 2023-03-01 | $584.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $457.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $921.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.06M 10-Q · filed 2022-11-08 | $842.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $464.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $608.00K 10-Q · filed 2022-08-08 | $385.00K derived: sum of 3 quarters · filed 2022-08-08 | $649.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $144.00K 10-Q · filed 2022-05-09 | -$79.00K derived: sum of 2 quarters · filed 2022-05-09 | $185.00K derived: sum of 3 quarters · filed 2022-05-09 | $191.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $41.00K derived: sum of 2 quarters · filed 2022-03-01 | $47.00K derived: sum of 3 quarters · filed 2022-03-01 | $65.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $264.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $270.00K derived: sum of 2 quarters · filed 2021-11-09 | $288.00K 10-Q · filed 2021-11-09 | $272.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $24.00K 10-Q · filed 2021-08-10 | $8.00K derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $18.00K 10-Q · filed 2021-05-12 | $2.00K derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $47.00K 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $63.00K 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |